Feed 4016.SR
40
Middle East Pharmaceutical Industries Company
4016.SR · SAU
59.30 SAR +0.51% (+0.30 SAR)
1M -2.56%
Market Cap 2.07B SAR
P/E Ratio 19.03x
Div. Yield -
ROE 26.29%
Bulios Fair Price
83.08 SAR
40.1% upside
Trenutna cena
59.3 SAR
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica 4016.SR trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
45 /100
Fair P/E 19.03x
EV/EBITDA 15.74x
P/S 4.03x
Growth
91 /100
Growing EPS growth 17.74%
Rev. growth 15.01%
FCF growth 21.16%
Profitability
87 /100
Strong Gross margin 62.30%
Net margin 21.19%
Op. margin 23.88%
Quality
94 /100
Excellent ROIC 19.44%
ROE 26.29%
ROA 15.74%
Debt
98 /100
Low Debt/Equity 0.25x
Current ratio 2.70x
Int. coverage 19.05x
Stability
91 /100
Stable Beta 0.45x
Rev. volatility 2.79%
EPS volatility 6.13%
Vprašajte StockBota o 4016.SR
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Mohammed Maher MohammedLotfi Al-Ghannam
Employees
731
Headquarters
Riyadh
Prihajajoči dogodki
01 SEP.
Ex-Dividend
Ex-dividend date
15 SEP.
Dividend Payment
Datum plačila